Miguel Perales MD

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine www.nytimes.com/2026/02/18/h...

Predicting chronic graft-versus-host disease

This issue’s cover features work by Sophie Paczesny @sophpacz.bsky.social & team on BIOPREVENT, a tree-based machine learning algorithm developed using data from 1,310 recipients of hematopoietic cell transplants: doi.org/10.1172/JCI1...

4 times as many measles cases in few weeks than US typically averages in year: CDC There have been 733 cases so far this year, a CDC report said.

Remember: In the prevaccine era, measles would peak in late winter- early spring. Don’t be surprised if in the next few weeks we see a surge

www.aol.com/articles/us-...

🎉 Congrats to Luis Diaz Jr., MD, on receiving the 2026 Gustave Roussy Award - Honored for groundbreaking work in precision oncology.
👉https://lfdn.org/3NXPdIs
#ResearchIsFundamental @mskcancercenter.bsky.social @gustaveroussy.fr

#tandem26 tradition - @astct.bsky.social Past President's Breakfast

Join global experts at the 2026 Tandem Meetings to explore the biological mechanisms driving acute and chronic GVHD, the latest clinical research and novel therapeutic approaches. Register today to attend these sessions: www.tandemmeetings.com

As part of the GVHD Alliance community, ASTCT is proud to raise awareness and connect people with trusted GVHD resources.

Learn more about GVHD and explore available resources as we prepare for GVHD Day on February 17.

www.gvhdalliance.org/resources/ #GVHDDay #GVHDAlliance #StrongerThanGVHD

Great presentation by my colleague Heather Landau on transformative results of BCMA #CARTcells for #amyloidosis #tandem26 @mskcancercenter.bsky.social @mskdeptofmed.bsky.social

In a "Best Abstracts" session at #Tandem26, Dr. Heather Landau will present the study, "First 23-Patient Safety and Efficacy Data from Nexicart-2, the First U.S. Trial of CAR-T in R/R Light Chain (AL) Amyloidosis, Nxc-201." @mskcancercenter.bsky.social

📍 Feb 6, 9:15 a.m. MST

https://bit.ly/46sXtGv

My Op Ed in Today's Washington Post: "The long-lasting effects of viruses — and the anti-vaccine movement. For some people, a viral infection can have devastating long-term effects."

wapo.st/4qjFtWk

What's next for HCT and cellular therapies? The #Tandem26 opening-day plenary examined progress from breakthrough to bedside — looking toward equitable access and improved care. Read more in Tandem Meeting News: www.tandemmeetingsnews.com/joint-plenar...

Congratulations to Amy and the whole @nmdp-org.bsky.social team. Proud to serve on their Board and work to improve outcomes for our patients.

🏆 NMDP is proud to receive the ASTCT Public Service Award at #Tandem2026, with CEO Amy Ronneberg recognized on behalf of our org.

Since 1987, NMDP has advanced transplantation & access to cell therapy—impacting 140,000+ lives. We thank ASTCT for recognizing that commitment with a meaningful honor!

Don't miss Dr. Moneeza Walji's #Tandem26 presentation, "Improved Social Drivers of Health: Support through a Novel Needs Assessment and Patient Navigation Program for Bone Marrow Transplant and Cellular Therapy Patients."

📍Feb 4, 4:30 p.m.

➡️ https://bit.ly/3ZS2zsc

@mskcancercenter.bsky.social

#Tandem26: Dr. Natalia Tijaro Ovalle will present the results of a phase 2 study evaluating precision melphalan dosing combined with siltuximab in older adults with #multiplemyeloma undergoing stem cell transplant.

📍Feb 5, 4:15 p.m. MST

➡️ https://bit.ly/49ZW3pn

@mskcancercenter.bsky.social

#tandem26 #bmtsm Auletta: world-wide unrelated and haplodentical donors are driving growth in alloHCT. PTCy has rapidly become predominant GVHD ppx across donor types.

Plenary session to examine latest advances to prevent GVHD - Tandem Meetings News Brian Shaffer, MD, previews a session on cyclophosphamide, gut microbiota and T-cell depleted transplantation.

Coming up at #Tandem26: Bone marrow transplant specialist & cellular therapist Dr. Brian Shaffer will moderate the plenary session, "Innovations in GVHD Prevention: PTCy & Beyond."

📍 Feb. 5, 5:00 – 6:30 p.m. MST | Salt Palace Convention Center, Ballroom AB.

@mskcancercenter.bsky.social

Celebrating @cibmtr.bsky.social Mary Horowitz on her retirement. It has been a privilege to work with her and learn from her over the years. Truly a giant in our field, a generous colleague and good friend.

I ran into @nmdp-org.bsky.social CEO Amy Ronneberg taking a break at #tandem26

Very honored for this recognition by my @astct.bsky.social colleagues.

Congrats to Dr. Miguel-Angel Perales, Chief of the Adult Bone Marrow Transplant Service at @mskcancercenter.bsky.social, on being inducted into the 2026 Class of the American Society of Transplantation and Cellular Therapy Fellows Program!@drmiguelperales.bsky.social #Tandem26

📷: @astct.bsky.social

Roisin E. O'Cearbhaill, MD How Do We Meet the Challenge of Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors? #tandem26 journals.lww.com/journalppo/f...

Roisin E. O'Cearbhaill @mskcancercenter.bsky.social at #tandem26

My @mskcancercenter.bsky.social colleague Dr Roisin E. O'Cearbhaill discussing role of cell therapy at #tandem26 Joint session @astct.bsky.social @sitcancer.bsky.social #tcellrx #cartcells

Congratulations to our 2026 Fellows of ASTCT (FASTCT) and past presidents Dr. Corey Cutler and Dr. Miguel-Angel Perales! #Tandem26 @drmiguelperales.bsky.social

At #Tandem26, don't miss Dr. Mohammad Alhomoud's presentation, "Cartiac: Comparative Cardiovascular Safety of CAR T Products for Non-Hodgkin’s Lymphoma – a Propensity Score–Matched International Multicenter Study."

📍 Feb 4, 4:15 PM MST

➡️ https://bit.ly/49XCUEv

@mskcancercenter.bsky.social

Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse - PubMed T cells are the central drivers of many inflammatory diseases, but the repertoire of tissue-resident T cells at sites of pathology in human organs remains poorly understood. We examined the site-specificity of T cell receptor (TCR) repertoires across tissues (5 to 18 tissues per patient) in prospect …

Dewolf et al @mskcancercenter.bsky.social #tandem26 pubmed.ncbi.nlm.nih.gov/37494469/

Susan Dewolf talking about crosstalk between mouse and human studies in leukemia and BMT #Tandem26 @mskcancercenter.bsky.social @mskdeptofmed.bsky.social

Dr. Miguel-Angel Perales (@drmiguelperales.bsky.social) concludes the CIBMTR Concurrent Session with “Use of CIBMTR One Year Survival Calculator for Retrospective Analysis” at #Tandem26 this morning!

Society for Immunotherapy of Cancer is proud to collaborate with ASTCT for a joint session, "Evolving Landscape of Cellular Therapy: Solid Tumors and Autoimmune Disorders," tomorrow, Feb. 5 at #Tandem26. Learn more and register here: https://tandemmeetings.swoogo.com/Tandem26